Literature DB >> 11172184

Is liver fibrosis reversible?

P A Bonis, S L Friedman, M M Kaplan.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11172184     DOI： 10.1056/NEJM200102083440610

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

1.  Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.

Authors:  Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Eun Hee Choi; Jae Yeon Seok; Jung Min Lee; Young Nyun Park; Chae Yoon Chon; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

2.  Effects of total glucosides of peony on immunological hepatic fibrosis in rats.

Authors:  Hua Wang; Wei Wei; Ni-Ping Wang; Cheng-Yi Wu; Shang-Xue Yan; Li Yue; Ling-Ling Zhang; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

3.  Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens.

Authors:  Fabio Grizzi; Carlo Russo; Barbara Franceschini; Mariagrazia Di Rocco; Valter Torri; Emanuela Morenghi; Luigi Rainiero Fassati; Nicola Dioguardi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  How could analyzing the activity of two matrix metalloproteinases unveil the cause of sudden cardiac death.

Authors:  Ivan Sosa; Aron Grubesic
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-06       Impact factor: 3.219

5.  How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Naoko Kato; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Atsushi Yao; Yasunobu Hirata; Masaaki Akahane; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-07-17       Impact factor: 1.731

6.  Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd-EOB-DTPA-enhanced MRI for estimation of liver function.

Authors:  Tomohide Yoneyama; Yoshihiko Fukukura; Kiyohisa Kamimura; Koji Takumi; Aya Umanodan; Shinichi Ueno; Masayuki Nakajo
Journal:  Eur Radiol       Date:  2013-12-20       Impact factor: 5.315

Review 7.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 8.  From fatty liver to fibrosis: a tale of "second hit".

Authors:  Metin Basaranoglu; Gökcen Basaranoglu; Hakan Sentürk
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  Assessment of liver fibrosis using fast strain-encoded MRI driven by inherent cardiac motion.

Authors:  Ahmed A Harouni; Ahmed M Gharib; Nael F Osman; Caryn Morse; Theo Heller; Khaled Z Abd-Elmoniem
Journal:  Magn Reson Med       Date:  2014-07-31       Impact factor: 4.668

10.  Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods.

Authors:  Ahmed F Abdalla; Khaled R Zalata; Abeer F Ismail; Gamal Shiha; Mohamed Attiya; Ahmed Abo-Alyazeed
Journal:  Fibrogenesis Tissue Repair       Date:  2009-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.